Top compounds associated with response to CYR61


Feature Type Standardized
Nominal ANOVA
mRNA Bosutinib FIMM pan-cancer AAC -1.8 0.8
mRNA Erlotinib FIMM pan-cancer AAC -0.66 0.01
mRNA Panobinostat CCLE pan-cancer AAC -0.41 3e-13
mRNA 17-AAG FIMM pan-cancer AAC -0.35 0.2
mRNA Vorinostat GDSC1000 pan-cancer AAC -0.33 3e-14
mRNA CEP-701 FIMM pan-cancer AAC -0.29 0.1
mRNA FK866 GDSC1000 pan-cancer AAC -0.29 2e-11
mRNA NPK76-II-72-1 GDSC1000 pan-cancer AAC -0.28 3e-12
mRNA GSK690693 GDSC1000 pan-cancer AAC -0.26 3e-09
mRNA lapatinib UHNBreast pan-cancer AAC -0.26 0.4
Download CSV